Free Trial
$100 Off. Every Year. Lock In MarketBeat All Access at $149
Claim the Rate Lock
Claim MarketBeat All Access Sale Promotion
Wedbush

Wedbush Analyst Recommendations & Stock Picks

View the latest stock recommendations issued by analysts at Wedbush. This page tracks publicly reported analyst upgrades and downgrades, buy/hold/sell ratings, and price target changes for publicly traded companies. All data is compiled from credible public sources and updated regularly to reflect new insights from Wedbush's equity research team. MarketBeat is not affiliated with or endorsed by Wedbush.

Average Return
00.00% 12-Month ROI
Total Ratings
956 Last 12 Months
Buy Ratings
739 Last 12 Months
Sell Ratings
18 Last 12 Months
Companies Covered
268 Last 12 Months
MarketRank™ evaluates a company based on dividend strength, earnings, valuation, analysts forecasts, and more.
Available with a MarketBeat All Access Subscription
MarketRank™Upgrade to All Access to use the All Ranks Filter
Media sentiment refers to the percentage of positive news stories versus negative news stories a company has received in the past week.
Available with a MarketBeat All Access Subscription
Media SentimentUpgrade to All Access to use the All Sentiments Filter
Analyst consensus is the average investment recommendation among Wall Street research analysts.
Available with a MarketBeat All Access Subscription
Analyst ConsensusUpgrade to All Access to use the All Ratings Filter
0 Results
CompanyCurrent PriceReport DateAnalystActionPrice TargetRating12-Month Recommendation ROIDetails
Avalo Therapeutics, Inc. stock logo
AVTX
Avalo Therapeutics
$6.93
-7.0%
10/23/2026Lower Price Target$34.00 ➝ $22.00OutperformView details for Wedbush rating of Avalo Therapeutics (NASDAQ:AVTX) on 10/23/2026
Roblox Corporation stock logo
RBLX
Roblox
$53.00
-1.8%
10/23/2026Boost Price Target$48.00 ➝ $55.00NeutralView details for Wedbush rating of Roblox (NYSE:RBLX) on 10/23/2026
Burford Capital Limited stock logo
BUR
Burford Capital
$3.36
-0.4%
10/22/2026Reiterated Rating$3.65NeutralView details for Wedbush rating of Burford Capital (NYSE:BUR) on 10/22/2026
Freddie Mac stock logo
FMCC
Freddie Mac
$3.71
-6.1%
10/22/2026Reiterated Rating$6.00OutperformView details for Wedbush rating of Freddie Mac (OTCMKTS:FMCC) on 10/22/2026
Fannie Mae stock logo
FNMA
Fannie Mae
$3.99
-5.2%
10/22/2026Reiterated Rating$3.50HoldView details for Wedbush rating of Fannie Mae (OTCMKTS:FNMA) on 10/22/2026
Meta Platforms, Inc. stock logo
META
Meta Platforms
$642.62
-1.0%
10/22/2026Boost Price Target$700.00 ➝ $730.00NeutralView details for Wedbush rating of Meta Platforms (NASDAQ:META) on 10/22/2026
Rithm Capital Corp. stock logo
RITM
Rithm Capital
$9.40
+8.2%
10/22/2026Reiterated Rating$10.00OutperformView details for Wedbush rating of Rithm Capital (NYSE:RITM) on 10/22/2026
Rithm Property Trust Inc. stock logo
RPT
Rithm Property Trust
$11.15
-2.6%
10/22/2026Reiterated Rating$13.50OutperformView details for Wedbush rating of Rithm Property Trust (NYSE:RPT) on 10/22/2026
SentinelOne, Inc. stock logo
S
SentinelOne
$24.05
+6.9%
10/22/2026Boost Price Target$25.00 ➝ $27.00OutperformView details for Wedbush rating of SentinelOne (NYSE:S) on 10/22/2026
Abivax SA Sponsored ADR stock logo
ABVX
Abivax
$88.01
-2.5%
10/21/2026Lower Price Target$118.00 ➝ $96.00NeutralView details for Wedbush rating of Abivax (NASDAQ:ABVX) on 10/21/2026
Arcus Biosciences, Inc. stock logo
RCUS
Arcus Biosciences
$18.54
-4.2%
10/21/2026Boost Price Target$43.00 ➝ $49.00OutperformView details for Wedbush rating of Arcus Biosciences (NYSE:RCUS) on 10/21/2026
Telix Pharmaceuticals Limited stock logo
TLX
Telix Pharmaceuticals
$9.15
-4.1%
10/21/2026Reiterated Rating$22.00OutperformView details for Wedbush rating of Telix Pharmaceuticals (NASDAQ:TLX) on 10/21/2026
Xencor, Inc. stock logo
XNCR
Xencor
$25.18
-2.6%
10/21/2026Reiterated Rating$30.00OutperformView details for Wedbush rating of Xencor (NASDAQ:XNCR) on 10/21/2026
Advanced Micro Devices, Inc. stock logo
AMD
Advanced Micro Devices
$516.79
+1.7%
10/20/2026Reiterated Rating$600.00OutperformView details for Wedbush rating of Advanced Micro Devices (NASDAQ:AMD) on 10/20/2026
Disc Medicine, Inc. stock logo
IRON
Disc Medicine
$74.51
-0.7%
10/19/2026Boost Price Target$100.00 ➝ $110.00OutperformView details for Wedbush rating of Disc Medicine (NASDAQ:IRON) on 10/19/2026
VeriSign, Inc. stock logo
VRSN
VeriSign
$300.32
-1.4%
10/19/2026Boost Price Target$341.00 ➝ $351.00OutperformView details for Wedbush rating of VeriSign (NASDAQ:VRSN) on 10/19/2026
Netflix, Inc. stock logo
NFLX
Netflix
$65.85
-1.8%
10/16/2026Lower Price Target$105.00 ➝ $90.00OutperformView details for Wedbush rating of Netflix (NASDAQ:NFLX) on 10/16/2026
Varonis Systems, Inc. stock logo
VRNS
Varonis Systems
$48.88
0.0%
10/16/2026Boost Price Target$46.00 ➝ $49.75NeutralView details for Wedbush rating of Varonis Systems (NASDAQ:VRNS) on 10/16/2026
Diebold Nixdorf, Incorporated stock logo
DBD
Diebold Nixdorf
$69.29
+0.0%
10/15/2026Reiterated Rating$100.00OutperformView details for Wedbush rating of Diebold Nixdorf (NYSE:DBD) on 10/15/2026
GlobalFoundries Inc. stock logo
GFS
GlobalFoundries
$44.39
+2.4%
10/15/2026Reiterated Rating$72.00NeutralView details for Wedbush rating of GlobalFoundries (NASDAQ:GFS) on 10/15/2026
Sutro Biopharma, Inc. stock logo
STRO
Sutro Biopharma
$9.33
-9.3%
10/15/2026Reiterated Rating$60.00OutperformView details for Wedbush rating of Sutro Biopharma (NASDAQ:STRO) on 10/15/2026
AppLovin Corporation stock logo
APP
AppLovin
$260.25
-1.5%
10/14/2026Lower Price Target$610.00 ➝ $560.00OutperformView details for Wedbush rating of AppLovin (NASDAQ:APP) on 10/14/2026
Beam Therapeutics Inc. stock logo
BEAM
Beam Therapeutics
$24.05
-2.1%
10/14/2026Reiterated Rating$65.00OutperformView details for Wedbush rating of Beam Therapeutics (NASDAQ:BEAM) on 10/14/2026
IMAX Corporation stock logo
IMAX
IMAX
$53.35
+2.0%
10/14/2026Boost Price Target$54.00 ➝ $60.00OutperformView details for Wedbush rating of IMAX (NYSE:IMAX) on 10/14/2026
Unity Software Inc. stock logo
U
Unity Software
$40.87
+1.5%
10/14/2026Boost Price Target$50.00 ➝ $55.00OutperformView details for Wedbush rating of Unity Software (NYSE:U) on 10/14/2026
CareTrust REIT, Inc. stock logo
CTRE
CareTrust REIT
$36.61
0.0%
10/13/2026 Set Price Target$44.00View details for Wedbush rating of CareTrust REIT (NYSE:CTRE) on 10/13/2026
IonQ, Inc. stock logo
IONQ
IonQ
$31.28
+0.4%
10/13/2026Reiterated Rating$75.00OutperformView details for Wedbush rating of IonQ (NYSE:IONQ) on 10/13/2026
Cognizant Technology Solutions Corporation stock logo
CTSH
Cognizant Technology Solutions
$70.54
-4.3%
10/9/2026Reiterated Rating$70.00OutperformView details for Wedbush rating of Cognizant Technology Solutions (NASDAQ:CTSH) on 10/9/2026
Elastic N.V. stock logo
ESTC
Elastic
$102.61
+4.5%
10/9/2026Reiterated Rating$125.00OutperformView details for Wedbush rating of Elastic (NYSE:ESTC) on 10/9/2026
argenex SE stock logo
ARGX
argenex
$873.71
-0.2%
10/8/2026Lower Price Target$1,150.00 ➝ $1,130.00OutperformView details for Wedbush rating of argenex (NASDAQ:ARGX) on 10/8/2026
Flutter Entertainment PLC stock logo
FLUT
Flutter Entertainment
$79.98
-2.1%
10/8/2026Lower Price Target$126.00 ➝ $110.00OutperformView details for Wedbush rating of Flutter Entertainment (NYSE:FLUT) on 10/8/2026
Rocket Pharmaceuticals, Inc. stock logo
RCKT
Rocket Pharmaceuticals
$2.29
-0.9%
10/7/2026Reiterated RatingOutperformView details for Wedbush rating of Rocket Pharmaceuticals (NASDAQ:RCKT) on 10/7/2026
Zscaler, Inc. stock logo
ZS
Zscaler
$255.15
+7.3%
10/7/2026Boost Price Target$215.00 ➝ $240.00OutperformView details for Wedbush rating of Zscaler (NASDAQ:ZS) on 10/7/2026
Cyclerion Therapeutics, Inc. stock logo
KRSA
Cyclerion Therapeutics
$31.31
-6.3%
10/5/2026Initiated Coverage$44.00OutperformView details for Wedbush rating of Cyclerion Therapeutics (NASDAQ:KRSA) on 10/5/2026
Shattuck Labs, Inc. stock logo
STTK
Shattuck Labs
$5.49
-2.0%
10/2/2026Boost Price Target$11.00 ➝ $14.00OutperformView details for Wedbush rating of Shattuck Labs (NASDAQ:STTK) on 10/2/2026
WAVE Life Sciences Ltd. stock logo
WVE
WAVE Life Sciences
$3.18
-5.1%
10/2/2026Set Price Target$13.00View details for Wedbush rating of WAVE Life Sciences (NASDAQ:WVE) on 10/2/2026
Liquidia Corporation stock logo
LQDA
Liquidia
$42.65
+7.5%
10/2/2026 Set Price Target$58.00View details for Wedbush rating of Liquidia (NASDAQ:LQDA) on 10/2/2026
Foghorn Therapeutics Inc. stock logo
FHTX
Foghorn Therapeutics
$2.00
-0.5%
10/2/2026Downgrade$10.00 ➝ $2.00Outperform ➝ NeutralView details for Wedbush rating of Foghorn Therapeutics (NASDAQ:FHTX) on 10/2/2026
Aktis Oncology stock logo
AKTS
Aktis Oncology
$15.73
-6.1%
10/2/2026Reiterated Rating$35.00OutperformView details for Wedbush rating of Aktis Oncology (NASDAQ:AKTS) on 10/2/2026
Cognizant Technology Solutions Corporation stock logo
CTSH
Cognizant Technology Solutions
$70.54
-4.3%
10/2/2026Reiterated Rating$70.00OutperformView details for Wedbush rating of Cognizant Technology Solutions (NASDAQ:CTSH) on 10/2/2026
A letter from Shannon Stansberry (Ad)

Porter Stansberry nearly canceled the entire project. When he first saw the claimed returns - only one down year in nearly two decades and total gains of almost 2,000% - his immediate reaction was disbelief. It took a trusted friend's personal vouching for Emmet Savage and a face-to-face trip to Ireland to change his mind. The full documentary, Investigating Project Prophet, is now live.tc pixel

Watch the full story and see the verified track record for yourself
Jade Biosciences, Inc. stock logo
JBIO
Jade Biosciences
$14.59
-2.1%
10/1/2026Reiterated Rating$47.00OutperformView details for Wedbush rating of Jade Biosciences (NASDAQ:JBIO) on 10/1/2026
Arcus Biosciences, Inc. stock logo
RCUS
Arcus Biosciences
$18.54
-4.2%
9/30/2026Reiterated Rating$43.00OutperformView details for Wedbush rating of Arcus Biosciences (NYSE:RCUS) on 9/30/2026
Zenas BioPharma, Inc. stock logo
ZBIO
Zenas BioPharma
$26.87
-4.8%
9/30/2026Reiterated Rating$45.00OutperformView details for Wedbush rating of Zenas BioPharma (NASDAQ:ZBIO) on 9/30/2026
Damora Therapeutics, Inc. Common Stock stock logo
DMRA
Damora Therapeutics, Inc. Common Stock
$21.09
-2.9%
9/29/2026Reiterated Rating$40.00OutperformView details for Wedbush rating of Damora Therapeutics, Inc. Common Stock (NASDAQ:DMRA) on 9/29/2026
Adicet Bio, Inc. stock logo
ACET
Adicet Bio
$3.99
-6.8%
9/28/2026Reiterated Rating$25.00 ➝ $28.00OutperformView details for Wedbush rating of Adicet Bio (NASDAQ:ACET) on 9/28/2026
Micron Technology, Inc. stock logo
MU
Micron Technology
$877.55
+2.5%
9/28/2026Reiterated Rating$1,400.00OutperformView details for Wedbush rating of Micron Technology (NASDAQ:MU) on 9/28/2026
Zscaler, Inc. stock logo
ZS
Zscaler
$255.15
+7.3%
9/28/2026Reiterated Rating$215.00OutperformView details for Wedbush rating of Zscaler (NASDAQ:ZS) on 9/28/2026
Oruka Therapeutics, Inc. stock logo
ORKA
Oruka Therapeutics
$80.15
-1.2%
9/24/2026Set Price Target$120.00View details for Wedbush rating of Oruka Therapeutics (NASDAQ:ORKA) on 9/24/2026
Eupraxia Pharmaceuticals Inc. stock logo
EPRX
Eupraxia Pharmaceuticals
$6.87
-9.5%
9/24/2026Initiated Coverage$17.00OutperformView details for Wedbush rating of Eupraxia Pharmaceuticals (NASDAQ:EPRX) on 9/24/2026
Oruka Therapeutics, Inc. stock logo
ORKA
Oruka Therapeutics
$80.15
-1.2%
9/24/2026Reiterated Rating$165.00OutperformView details for Wedbush rating of Oruka Therapeutics (NASDAQ:ORKA) on 9/24/2026
Everpure, Inc. stock logo
P
Everpure
$123.33
+1.8%
9/24/2026Reiterated Rating$130.00OutperformView details for Wedbush rating of Everpure (NYSE:P) on 9/24/2026
Roku, Inc. stock logo
ROKU
Roku
$158.58
-0.9%
9/24/2026Reiterated Rating$155.00NeutralView details for Wedbush rating of Roku (NASDAQ:ROKU) on 9/24/2026
Compass Therapeutics, Inc. stock logo
CMPX
Compass Therapeutics
$0.76
-5.1%
9/23/2026Set Price Target$4.00View details for Wedbush rating of Compass Therapeutics (NASDAQ:CMPX) on 9/23/2026
Maze Therapeutics, Inc. stock logo
MAZE
Maze Therapeutics
$31.01
-2.9%
9/23/2026Reiterated Rating$48.00OutperformView details for Wedbush rating of Maze Therapeutics (NASDAQ:MAZE) on 9/23/2026
Nektar Therapeutics stock logo
NKTR
Nektar Therapeutics
$37.22
-3.7%
9/23/2026Lower Price Target$80.00 ➝ $50.00NeutralView details for Wedbush rating of Nektar Therapeutics (NASDAQ:NKTR) on 9/23/2026
Shopify Inc. stock logo
SHOP
Shopify
$168.68
-0.1%
9/23/2026Reiterated Rating$176.00OutperformView details for Wedbush rating of Shopify (NASDAQ:SHOP) on 9/23/2026
Telix Pharmaceuticals Limited stock logo
TLX
Telix Pharmaceuticals
$9.15
-4.1%
9/23/2026Reiterated Rating$22.00OutperformView details for Wedbush rating of Telix Pharmaceuticals (NASDAQ:TLX) on 9/23/2026
Willdan Group, Inc. stock logo
WLDN
Willdan Group
$72.48
+0.6%
9/23/2026Reiterated Rating$130.00OutperformView details for Wedbush rating of Willdan Group (NASDAQ:WLDN) on 9/23/2026
Compass Therapeutics, Inc. stock logo
CMPX
Compass Therapeutics
$0.76
-5.1%
9/22/2026Downgrade$5.00 ➝ $1.00Outperform ➝ NeutralView details for Wedbush rating of Compass Therapeutics (NASDAQ:CMPX) on 9/22/2026
Abivax SA Sponsored ADR stock logo
ABVX
Abivax
$88.01
-2.5%
9/22/2026Lower Price Target$140.00 ➝ $118.00NeutralView details for Wedbush rating of Abivax (NASDAQ:ABVX) on 9/22/2026
IonQ, Inc. stock logo
IONQ
IonQ
$31.28
+0.4%
9/22/2026Reiterated Rating$75.00OutperformView details for Wedbush rating of IonQ (NYSE:IONQ) on 9/22/2026
Travere Therapeutics, Inc. stock logo
TVTX
Travere Therapeutics
$50.08
-4.5%
9/22/2026Reiterated Rating$76.00OutperformView details for Wedbush rating of Travere Therapeutics (NASDAQ:TVTX) on 9/22/2026
fuboTV Inc. stock logo
FUBO
fuboTV
$7.93
-2.8%
9/18/2026Reiterated Rating$19.00OutperformView details for Wedbush rating of fuboTV (NYSE:FUBO) on 9/18/2026
Xenon Pharmaceuticals Inc. stock logo
XENE
Xenon Pharmaceuticals
$35.34
-3.2%
9/18/2026Lower Price Target$71.00 ➝ $55.00OutperformView details for Wedbush rating of Xenon Pharmaceuticals (NASDAQ:XENE) on 9/18/2026
Cogent Biosciences, Inc. stock logo
COGT
Cogent Biosciences
$31.21
-0.3%
9/16/2026Reiterated Rating$55.00OutperformView details for Wedbush rating of Cogent Biosciences (NASDAQ:COGT) on 9/16/2026
Nuvation Bio Inc. stock logo
NUVB
Nuvation Bio
$4.57
-2.9%
9/16/2026Reiterated Rating$11.00OutperformView details for Wedbush rating of Nuvation Bio (NYSE:NUVB) on 9/16/2026
Rocket Pharmaceuticals, Inc. stock logo
RCKT
Rocket Pharmaceuticals
$2.29
-0.9%
9/16/2026Reiterated Rating$15.00OutperformView details for Wedbush rating of Rocket Pharmaceuticals (NASDAQ:RCKT) on 9/16/2026
Scholar Rock Holding Corporation stock logo
SRRK
Scholar Rock
$41.49
-1.1%
9/15/2026Reiterated Rating$64.00OutperformView details for Wedbush rating of Scholar Rock (NASDAQ:SRRK) on 9/15/2026
Benitec Biopharma Limited stock logo
BNTC
Benitec Biopharma
$8.65
-1.9%
9/15/2026Boost Price Target$16.00 ➝ $17.00OutperformView details for Wedbush rating of Benitec Biopharma (NASDAQ:BNTC) on 9/15/2026
Perspective Therapeutics, Inc. stock logo
CATX
Perspective Therapeutics
$1.61
-28.8%
9/15/2026Reiterated Rating$11.00OutperformView details for Wedbush rating of Perspective Therapeutics (NYSEAMERICAN:CATX) on 9/15/2026
Sionna Therapeutics, Inc. stock logo
SION
Sionna Therapeutics
$3.60
-5.3%
9/15/2026Boost Price Target$5.00 ➝ $6.00NeutralView details for Wedbush rating of Sionna Therapeutics (NASDAQ:SION) on 9/15/2026
Crescent Biopharma, Inc. stock logo
CBIO
Crescent Biopharma
$12.82
-2.4%
9/14/2026Reiterated Rating$27.00OutperformView details for Wedbush rating of Crescent Biopharma (NASDAQ:CBIO) on 9/14/2026
Roblox Corporation stock logo
RBLX
Roblox
$53.00
-1.8%
9/14/2026Boost Price Target$40.00 ➝ $48.00NeutralView details for Wedbush rating of Roblox (NYSE:RBLX) on 9/14/2026
Scholar Rock Holding Corporation stock logo
SRRK
Scholar Rock
$41.49
-1.1%
9/14/2026Reiterated Rating$64.00OutperformView details for Wedbush rating of Scholar Rock (NASDAQ:SRRK) on 9/14/2026
Telix Pharmaceuticals Limited stock logo
TLX
Telix Pharmaceuticals
$9.15
-4.1%
9/14/2026Reiterated Rating$22.00OutperformView details for Wedbush rating of Telix Pharmaceuticals (NASDAQ:TLX) on 9/14/2026
Meta Platforms, Inc. stock logo
META
Meta Platforms
$642.62
-1.0%
9/11/2026Boost Price Target$595.00 ➝ $650.00NeutralView details for Wedbush rating of Meta Platforms (NASDAQ:META) on 9/11/2026
CrowdStrike stock logo
CRWD
CrowdStrike
$257.57
+8.2%
9/11/2026Reiterated Rating$250.00OutperformView details for Wedbush rating of CrowdStrike (NASDAQ:CRWD) on 9/11/2026
Datadog, Inc. stock logo
DDOG
Datadog
$269.65
+4.6%
9/11/2026Initiated Coverage$260.00 ➝ $275.00OutperformView details for Wedbush rating of Datadog (NASDAQ:DDOG) on 9/11/2026
Elastic N.V. stock logo
ESTC
Elastic
$102.61
+4.5%
9/11/2026Initiated Coverage$125.00OutperformView details for Wedbush rating of Elastic (NYSE:ESTC) on 9/11/2026
Palo Alto Networks, Inc. stock logo
PANW
Palo Alto Networks
$380.55
+7.2%
9/11/2026Initiated Coverage$400.00OutperformView details for Wedbush rating of Palo Alto Networks (NASDAQ:PANW) on 9/11/2026
Rubrik, Inc. stock logo
RBRK
Rubrik
$129.18
+7.0%
9/11/2026Initiated Coverage$90.00 ➝ $120.00OutperformView details for Wedbush rating of Rubrik (NYSE:RBRK) on 9/11/2026
SentinelOne, Inc. stock logo
S
SentinelOne
$24.05
+6.9%
9/11/2026Initiated Coverage$25.00OutperformView details for Wedbush rating of SentinelOne (NYSE:S) on 9/11/2026
Varonis Systems, Inc. stock logo
VRNS
Varonis Systems
$48.88
0.0%
9/11/2026Reiterated Rating$46.00Outperform ➝ NeutralView details for Wedbush rating of Varonis Systems (NASDAQ:VRNS) on 9/11/2026
Zscaler, Inc. stock logo
ZS
Zscaler
$255.15
+7.3%
9/11/2026Initiated Coverage$215.00OutperformView details for Wedbush rating of Zscaler (NASDAQ:ZS) on 9/11/2026
Qualys, Inc. stock logo
QLYS
Qualys
$216.70
+4.1%
9/10/2026Downgrade$175.00Outperform ➝ NeutralView details for Wedbush rating of Qualys (NASDAQ:QLYS) on 9/10/2026
Telos Corporation stock logo
TLS
Telos
$4.87
+6.6%
9/10/2026Downgrade$5.00Outperform ➝ NeutralView details for Wedbush rating of Telos (NASDAQ:TLS) on 9/10/2026
Dynatrace, Inc. stock logo
DT
Dynatrace
$64.14
+1.2%
9/10/2026Downgrade$54.00Outperform ➝ NeutralView details for Wedbush rating of Dynatrace (NYSE:DT) on 9/10/2026
Check Point Software Technologies Ltd. stock logo
CHKP
Check Point Software Technologies
$159.03
+4.6%
9/10/2026Downgrade$135.00Outperform ➝ NeutralView details for Wedbush rating of Check Point Software Technologies (NASDAQ:CHKP) on 9/10/2026
Tenable Holdings, Inc. stock logo
TENB
Tenable
$44.59
+6.2%
9/10/2026Downgrade$29.00Outperform ➝ UnderperformView details for Wedbush rating of Tenable (NASDAQ:TENB) on 9/10/2026
Pyxis Oncology, Inc. stock logo
PYXS
Pyxis Oncology
$1.68
-1.8%
9/10/2026Boost Price Target$6.00 ➝ $8.00OutperformView details for Wedbush rating of Pyxis Oncology (NASDAQ:PYXS) on 9/10/2026
Why Gerardo Del Real says wait before buying uranium stocks (Ad)

Gerardo Del Real is calling it the Third Convergence Event, a new catalyst hitting the uranium market that he says has never existed before. In a similar setup in the past, select investors saw $1,000 turn into over $1 million within a few years. Del Real just released a full video breakdown of what is driving this move and how to prepare.tc pixel

Watch Gerardo Del Real's new uranium market breakdown now
Datadog, Inc. stock logo
DDOG
Datadog
$269.65
+4.6%
9/10/2026UpgradeStrong-BuyView details for Wedbush rating of Datadog (NASDAQ:DDOG) on 9/10/2026
Dynatrace, Inc. stock logo
DT
Dynatrace
$64.14
+1.2%
9/10/2026UpgradeHoldView details for Wedbush rating of Dynatrace (NYSE:DT) on 9/10/2026
Immunic, Inc. stock logo
IMUX
Immunic
$7.41
+2.6%
9/10/2026Reiterated Rating$45.00OutperformView details for Wedbush rating of Immunic (NASDAQ:IMUX) on 9/10/2026
Opus Genetics, Inc. stock logo
IRD
Opus Genetics
$3.47
-9.2%
9/10/2026Boost Price Target$10.00 ➝ $13.00OutperformView details for Wedbush rating of Opus Genetics (NASDAQ:IRD) on 9/10/2026
Disc Medicine, Inc. stock logo
IRON
Disc Medicine
$74.51
-0.7%
9/10/2026Reiterated Rating$100.00OutperformView details for Wedbush rating of Disc Medicine (NASDAQ:IRON) on 9/10/2026
Qualys, Inc. stock logo
QLYS
Qualys
$216.70
+4.1%
9/10/2026UpgradeHoldView details for Wedbush rating of Qualys (NASDAQ:QLYS) on 9/10/2026
Tenable Holdings, Inc. stock logo
TENB
Tenable
$44.59
+6.2%
9/10/2026UpgradeStrong SellView details for Wedbush rating of Tenable (NASDAQ:TENB) on 9/10/2026
Telos Corporation stock logo
TLS
Telos
$4.87
+6.6%
9/10/2026UpgradeHoldView details for Wedbush rating of Telos (NASDAQ:TLS) on 9/10/2026
Tyra Biosciences, Inc. stock logo
TYRA
Tyra Biosciences
$20.45
-2.0%
9/10/2026Reiterated Rating$53.00OutperformView details for Wedbush rating of Tyra Biosciences (NASDAQ:TYRA) on 9/10/2026
Varonis Systems, Inc. stock logo
VRNS
Varonis Systems
$48.88
0.0%
9/10/2026UpgradeHoldView details for Wedbush rating of Varonis Systems (NASDAQ:VRNS) on 9/10/2026

MarketBeat's community ratings are surveys of what our community members think about Wedbush and other research firms in the last 90 days. Vote "Outperform" if you believe Wedbush's recommendations will outperform the broader market over the long term. Vote "Underperform" if you believe Wedbush's recommendations will underperform the broader market over the long term. You may vote once every thirty days.

Log in to vote on this brokerage.
COMMUNITY RATINGS
0.0out of 5 (last 90 days)
0 of 5 stars
OUTPERFORM VOTES
0 Believe will outperform the market
UNDERPERFORM VOTES
0 Believe will underperform the market

Wedbush's equity research team has issued ratings on 266 companies across 10 sectors over the past 12 months, covered by 18 analysts. The Wedbush analysts below are listed by number of ratings issued in the last year.

Wedbush Stock Coverage by Sector

Wedbush concentrates its research most heavily in Healthcare (44.4%), Technology (25.0%) and Consumer Discretionary (10.1%). The chart below shows how Wedbush's 268 rated companies are distributed across all 10 sectors it covers.

Wedbush - Frequently Asked Questions

Wedbush's analysts currently have buy-equivalent ratings on 223 companies. Recent upgrades to buy include Eupraxia Pharmaceuticals, Datadog, Replimune Group, Airbnb and SK hynix.

Wedbush's highest-rated analysts by MarketBeat's accuracy score include Laura Chico, Robert Driscoll and David Nierengarten. Rankings are based on historical rating accuracy and price target precision over the past 12 months. MarketBeat tracks 20 analysts at Wedbush.

Wedbush has the deepest coverage in Healthcare (44.4% of rated companies), Technology (25.0% of rated companies), Consumer Discretionary (10.1% of rated companies), Communication Services (8.6% of rated companies) and Industrials (4.9% of rated companies).

Wedbush issued 956 ratings over the last 12 months across 268 companies — an average of roughly 80 rating actions per month. These include boost price target, downgrade, initiated coverage, lower price target, reiterated rating, set price target and upgrade. MarketBeat tracks every rating change as it's published so you can see the most current Wedbush analyst actions.

A buy rating indicates the analyst expects the stock to outperform the market over the next 12 months. A hold suggests the stock will perform in line with the market. A sell rating indicates expected underperformance. Wedbush uses Outperform, Neutral, and Underperform as their equivalents.